ERIN JONES: Open Payments
NPI 1184959389 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,206 in 100 payments from 23 companies in 2025. Trend: 2023 $915 · 2024 $2,009 · 2025 $2,206
Food & beverage: $2,107Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $332 |
| ABBVIE INC. | 11 | $322 |
| Daiichi Sankyo Inc. | 15 | $235 |
| AstraZeneca Pharmaceuticals LP | 9 | $180 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $168 |
| PFIZER INC. | 3 | $140 |
| GENZYME CORPORATION | 5 | $125 |
| SOBI, INC | 1 | $99 |
| Janssen Biotech, Inc. | 5 | $95 |
| Genmab U.S., Inc. | 3 | $67 |
Products named: EPKINLY, ENHERTU, Nubeqa, SARCLISA, ERLEADA, ADCETRIS, SCEMBLIX, VENCLEXTA.
Industry payments across OK — which companies pay providers there.
